Unfortunately, high-risk patients have poor prognoses, including those with large tumor masses, older children (≥ 8 years old) and those with tumor metastasis or low concentrations of AFP (α fetoprotein ≤ 100 ng/mL) at diagnosis, and there is considerable room for improvement regarding outcomes [5]. This evidence concerns the gene AFP and neoplasm.